使用机器学习探索推动多发性硬化症慢性病变演变的因素
Hai Hu1,2, Long Ye1,3, Ping Wu4
1Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
European radiology
|June 17, 2025
概括
机器学习准确地预测慢性多发性硬化症 (MS) 病变的变化. 影响病变演变的关键因素包括慢性炎症,疾病持续时间和微观结构损伤.
科学领域:
- 神经成像是一种神经成像.
- 机器学习 机器学习
- 神经学 神经学
背景情况:
- 多发性硬化症 (MS) 是一种影响中枢神经系统的慢性炎症性疾病.
- 慢性多发性硬化病变的演变是可变的,并未完全理解.
- 预测病变变化对于了解疾病进展至关重要.
研究的目的:
- 开发一种机器学习模型,预测MS中慢性病变的体积变化.
- 确定影响慢性多发性硬化病变演变的关键因素.
主要方法:
- 分析了复发性复发性多发性硬化症 (RRMS) 患者的长度数据.
- 定量敏感度测绘 (QSM) 确定了"铁边缘"标志.
- T1/FLAIR比率量化了微观结构损伤.
- 机器学习模型 (SVM,RF,LR) 被训练来预测损伤体积的变化.
主要成果:
- 一种支持向量机 (SVM) 模型显示出高的预测效率 (AUC 0.90训练,0.81测试).
- 损伤体积变化的最重要的预测因素是"铁边"标志,疾病持续时间 (DD) 和T1/FLAIR比率.
- 这项研究分析了47名RRMS患者和833名慢性病变的数据.
结论:
- 机器学习模型可以有效地预测慢性多发性硬化病变体积结果.
- 病变周围的慢性炎症,疾病持续时间和微观结构损伤是病变演变的关键因素.
- 这些发现增强了我们对MS病变动态的理解.
相关概念视频
Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Hebbian LTP
LTP can occur when presynaptic neurons...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


